Skip to main content
See every side of every news story
Published loading...Updated

PTC Therapeutics (NASDAQ:PTCT) Insider Neil Gregory Almstead Sells 881 Shares of Stock

Multiple PTC Therapeutics executives sold shares at mid-$70 prices between Jan 6–12, amid strong earnings showing 7.2% revenue growth, according to SEC filings.

Summary
PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) insider Neil Gregory Almstead sold 881 shares of the business’s stock in a transaction dated Thursday, January 8th. The shares were sold at an average price of $76.45, for a total value of $67,352.45. Following the sale, the insider owned 115,196 shares in the company, valued at approximately $8,806,734.20. The trade was a 0.76% decrease in their position. The transaction was disclosed in a …

4 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

defenseworld.net broke the news in on Tuesday, January 13, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal